A biotech executive committed insider trading when he bet on a competitor's stock, believing the shares would rise when news about his own company hit the market, a jury found.
A biotech executive committed insider trading when he bet on a competitor’s stock, believing the shares would rise when news about his own company hit the market, a jury found.
A biotech executive committed insider trading when he bet on a competitor’s stock, believing the shares would rise when news about his own company hit the market, a jury found.
